two endogenous substances , prostacyclin ( pgi2 ) and thromboxane ( txa2 ) , have recently been shown to possess significant vascular and thrombotic activity and are known to be altered in atherosclerosis , thrombotic conditions , and diabetes .
C0033567
pgi2
C0003850
atherosclerosis